Skip to main content
. Author manuscript; available in PMC: 2021 Aug 16.
Published in final edited form as: J Urol. 2015 Jul 11;194(5):1214–1219. doi: 10.1016/j.juro.2015.05.104

Table 2.

Multivariate Cox regression analysis of RFS in patients treated with BCG with or without ACE-I/ARB

Stage (treatment) HR (95% CI) p Value
Ta: 0.04
 BCG Referent
 BCG + ACE-I/ARB 0.45 (0.21–0.98)
T1: 0.19
 BCG Referent
 BCG + ACE-I/ARB 0.53 (0.21–1.39)
CIS: 0.82
 BCG Referent
 BCG + ACE-I/ARB 1.19 (0.25–5.78)